Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Mosgorlombard recommended that dividends be paid for 2023

4/18/24 MGKL

Phosagro allocates to investments a record ₽73 billion

4/18/24 PHOR

PhosAgro sales up 11.5% in Q1

4/18/24 PHOR

Dialext successfully closed the investment raising round

4/18/24 OTCI

Delimobile doubles its truck fleet

4/18/24 DELI

MMK reported a decline in all indicators in Q1

4/18/24 MAGN

Tinkoff will receive Rosbank's retail business by the end of 2024

4/18/24 T

Kyuchus went up by 20%

4/18/24 SELG

Static testing of SSJ New to be completed in 2025

4/18/24 UNAC

Astra raised the lower bound of the SPO

4/18/24 ASTR